Cancer Research

Published by: American Association for Cancer Research  

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Fuks
    Fuks
  4. Kolesnick
    Kolesnick
  5. Chiosis
    Chiosis
  6. Haimovitz-Friedman
    Haimovitz-Friedman
  7. Blasberg
    Blasberg
  8. Chandarlapaty
    Chandarlapaty
  9. Danishefsky
    Danishefsky
  10. Clarkson
    Clarkson

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (340)
  2. Sloan Kettering Institute Faculty (340)
  3. GSK Faculty (292)
  4. Department of Medicine (227)
  5. Solid Tumor Oncology Division (133)
  6. Breast Medicine Service (106)
  7. Sloan Kettering Institute Postdocs (105)
  8. Center for Hematologic Malignancies (99)
  9. Hematologic Malignancies Research (87)
  10. Human Oncology and Pathogenesis Program (81)
Search Within
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (213)
  2. Journal Article (120)
  3. Conference Paper (5)
  4. Editorial (2)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (340)
  2. Sloan Kettering Institute Faculty (340)
  3. GSK Faculty (292)
  4. Department of Medicine (227)
  5. Solid Tumor Oncology Division (133)
  6. Breast Medicine Service (106)

More Groups

People
  1. Neal Rosen (99)
  2. David Solit (44)
  3. Zvi Fuks (41)
  4. Richard Kolesnick (37)
  5. Gabriela Chiosis (33)
  6. Adriana Haimovitz-Friedman (31)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (13)
  5. 2021 (6)
  6. 2020 (13)

More Years

Publishers
  1. American Association for Cancer Research (340)

Results (340)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Dotting out AML by targeting fibrillarin
    Editorial

    Luo, H.; Kharas, M. G.
    Cancer Research (2024)

    Fulltext@MSK | Save
  • Epigenetic cooperativity as a therapeutic vulnerability in cancer
    Editorial

    Kazansky, Y.; Kentsis, A.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SMYD2 regulates chromatin modifier KMT2D in ER+/PIK3CA mutant breast cancer
    Meeting Abstract

    Blawski, R.; Sallaku, M.; Guo, X.; Kittane, S.; Scaltriti, M.; Luo, M.; Toska, E.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MEKi-FGFRi combination nanoparticles for use against KRAS(mt)/FGFR-compensatory lung tumors
    Meeting Abstract

    Izawa-Ishiguro, A. R.; Sridharan, R.; Wun, C.; Sami, T. J.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save

    • Cancer Research – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association Tor Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 Unknown
    Cancer research 15387445 The Authors the American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 15387445 American Association for Cancer Research
    Cancer research 15387445 American Association for Cancer Research
    Cancer Research 00085472 Unknown
    Cancer Research 00085472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer research 15387445 Unknown
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 0008-5472 American Association for Cancer Research
    Cancer Research 00085472 American Association for Cancer
    Cancer Research 00085472 The Authors
    Cancer Research 00085472 The Authors the American Association for Cancer Research